MW Gestion v. Global Cord Blood Corporation et al: Class Action Complaint (‘Securities Fraud’)
Class Action Complaint in MW Gestion, described as "an institutional asset manager based in France" v. Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based company that "provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People’s Republic of China"; Ting Zheng, Bing Chuen, a.k.a. Albert Chen; Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, of the Cayman Islands; Golden Meditech Stem Cells (BVI) Company Limited, of the British Virgin Islands; GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech Precision Medicine Limited, of Hong Kong; Golden Meditech (BVI) Company Limited, of the British Virgin Islands, and KPMG Huazhen LLP at the U.S. District Court for the Southern District of New York.
